LASA.NS
Price:
$16.41
Market Cap:
$822.16M
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-09-21
Stock Exchange
NSE
Ticker
LASA.NS
According to Lasa Supergenerics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -5.21. This represents a change of 17.70% compared to the average of -4.43 of the last 4 quarters.
The mean historical PE Ratio of Lasa Supergenerics Limited over the last ten years is 15.07. The current -5.21 PE Ratio has changed -3557.45% with respect to the historical average. Over the past ten years (40 quarters), LASA.NS's PE Ratio was at its highest in in the June 2021 quarter at 102.25. The PE Ratio was at its lowest in in the September 2023 quarter at -1436.57.
Average
15.07
Median
0
Minimum
-39.43
Maximum
128.53
Discovering the peaks and valleys of Lasa Supergenerics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 128.53
Minimum Annual Increase = -800.56%
Minimum Annual PE Ratio = -39.43
Year | PE Ratio | Change |
---|---|---|
2024 | -5.32 | 121.18% |
2023 | -2.41 | -93.90% |
2022 | -39.43 | -469.30% |
2021 | 10.68 | -64.98% |
2020 | 30.49 | -800.56% |
2019 | -4.35 | -124.96% |
2018 | 17.44 | -86.44% |
2017 | 128.53 | Infinity% |
The current PE Ratio of Lasa Supergenerics Limited (LASA.NS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-15.72
5-year avg
-1.20
10-year avg
15.07
Lasa Supergenerics Limited’s PE Ratio is less than Lincoln Pharmaceuticals Limited (12.51), less than Mangalam Drugs & Organics Limited (12.70), less than Ind-Swift Laboratories Limited (1.78), greater than Krebs Biochemicals & Industries Limited (-6.67), less than Hester Biosciences Limited (50.03),
Company | PE Ratio | Market cap |
---|---|---|
12.51 | $11.18B | |
12.70 | $1.29B | |
1.78 | $4.38B | |
-6.67 | $1.64B | |
50.03 | $15.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lasa Supergenerics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lasa Supergenerics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lasa Supergenerics Limited's PE Ratio?
How is the PE Ratio calculated for Lasa Supergenerics Limited (LASA.NS)?
What is the highest PE Ratio for Lasa Supergenerics Limited (LASA.NS)?
What is the 3-year average PE Ratio for Lasa Supergenerics Limited (LASA.NS)?
What is the 5-year average PE Ratio for Lasa Supergenerics Limited (LASA.NS)?
How does the current PE Ratio for Lasa Supergenerics Limited (LASA.NS) compare to its historical average?